Annual Low-Dose Whole-Body CT Scan Enhances Monitoring of Smoldering Multiple Myeloma
Recent research has demonstrated that conducting yearly low-dose whole-body computed tomography (WBLDCT) scans significantly improves the management of patients with smoldering multiple myeloma (SMM). The study, published online on March 25 in the Journal of Clinical Medicine, highlights the important role of early detection of disease progression in this patient population.
Led by Dr. Ioannis Ntanasis-Stathopoulos from the General Alexandra Hospital and the National and Kapodistrian University of Athens in Greece, the research involved evaluating 113 patients with SMM who underwent annual WBLDCT assessments. The primary focus was on identifying early signs of bone deterioration and progression to symptomatic multiple myeloma.
The findings revealed that approximately 36.3% of the studied patients progressed to active multiple myeloma over the follow-up period. Notably, nearly 10% of these cases exhibited disease progression solely through the appearance of new bone lesions, emphasizing the crucial role of imaging in early detection.
The authors concluded that incorporating yearly WBLDCT scans into routine care for SMM patients can significantly aid in early detection of disease progression. Due to the strong association between radiologically detected bone lesions and progression risk, these imaging assessments are recommended to refine patient monitoring strategies and optimize management approaches.
This study underscores the importance of regular imaging in the early intervention of smoldering multiple myeloma, potentially leading to improved patient outcomes.
Source: https://medicalxpress.com/news/2025-04-annual-body-dose-ct-aids.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Early Life Factors and Their Role in Developing Multiple Sclerosis
Recent research highlights how childhood infections, stress, maternal age, and physical activity levels can influence the risk of developing multiple sclerosis later in life. Discover how early-life factors may impact MS development and prevention strategies.
RSV Vaccination Programs Reduce Hospital Burden and Costly Treatments in Australia
Australia's RSV vaccination program has significantly lowered hospitalization rates in infants, saving millions in healthcare costs and marking a major step forward in disease prevention.
FDA Recalls Six Popular Acne Products Due to Benzene Contamination
The FDA has recalled six popular acne treatments after tests revealed dangerous benzene contamination. This chemical, linked to cancer, forms when benzoyl peroxide breaks down, raising safety concerns. Learn more about the risks and safety measures.
Emerging 'Designer Drugs' Threaten Road Safety in the United States
New research highlights the rising threat of designer drugs to road safety in the US, emphasizing the need for expanded drug testing and awareness of synthetic opioids' dangers.